pharma · Advanced Solid Tumor · Chronic Lymphocytic Leukemia
BEONE MEDICINES AUS
BEONE MEDICINES AUS PTY LTD
NovaPharmaNews editorial coverage mentioning BEONE MEDICINES AUS — regulatory, clinical, and market analysis.
Company details
- Status
- Public
- HQ
- Cambridge, USA
- Founded
- 2010
- Employees
- 3,177
- Programs
- 122
- Drugs
- 63
- Patents
- 0
News & analysis
NovaPharmaNews articles mentioning BEONE MEDICINES AUS — regulatory, clinical, and market coverage.
NovaPharmaNews editorial coverage mentioning BEONE MEDICINES AUS — regulatory, clinical, and market analysis.
ASCO26: Summit, Akeso claim OS victory for ivonescimab in pivotal Chinese study
Structured plan for ASCO26: Summit, Akeso claim OS victory for ivonescimab in pivotal Chinese study
BeOne Medicines' HERIZON-GEA Phase 3 Data in NEJM: A Deep Dive for Pharma BD and Investors
BeOne Medicines has announced the publication of its Phase 3 HERIZON-GEA trial data in The New England Journal of Medicine (NEJM). This development offers significant insights for pharmaceutical business development teams and investors evaluating the company's pipeline and market potential.